ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Evaluating Postoperative Opioid Requirements of Kidney Transplant Recipients

M. A. Muir1, K. R. Szempruch2, R. E. Dupuis1, A. H. Toledo3, P. Serrano Rodriguez3

1Pharmacotherapy and Experimental Therapeutics, UNC Eshleman School of Pharmacy, Chapel Hill, NC, 2Pharmacy, UNC Medical Center, Chapel Hill, NC, 3Surgery - Transplant, UNC Medical Center, Chapel Hill, NC

Meeting: 2020 American Transplant Congress

Abstract number: LB-032

Keywords: Kidney transplantation, Outcome, Pain

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session C: Late Breaking

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Opioid Utilization Post-Operatively in Kidney Transplantation
  • Evaluation of an Opioid Restrictive Pain Management Initiative in Adult Kidney Transplant Recipients

*Purpose: Multimodal analgesia with non-opioid analgesics in the setting of enhanced recovery after surgery (ERAS) pathway has proven beneficial in managing pain and decreasing adverse outcomes in kidney donors following surgery. Data assessing similar outcomes in kidney transplant recipients (KTRs) is limited. The purpose of this study was to evaluate the effectiveness of implementing an ERAS pathway to limit overall narcotic use in KTRs.

*Methods: This retrospective study of KTRs included recipients >18 years old who received a kidney transplant between January 2017 to July 2019. The ERAS pathway, which included scheduled acetaminophen, gabapentin, and as needed tramadol for multimodal analgesia, was implemented in August 2018. Recipients were excluded if they received a dual organ transplant. The primary endpoint was to compare ERAS vs non-ERAS opioid requirements in morphine milligram equivalents (MME) during transplant admission. Secondary endpoints included comparison of pain scores, length of stay, opioid use six months post-discharge, re-admissions within one month post-discharge, and the evaluation of KTRs that did not follow ERAS after implementation.

*Results: 217 KTRs met criteria with no significant differences in age, gender, race or donor type between ERAS and non-ERAS cohorts. Inpatient opioid use was significantly reduced following implementation of ERAS along with a significant reduction of overall opioid use post-discharge (Table 1). However, inpatient opioid use in the living donor recipients and average inpatient pain scores were not significantly different. Readmissions were significantly reduced in the ERAS cohort compared to non-ERAS (15 vs 56, p<0.02). For KTRs who did not follow ERAS (n=30), 27% were on opioids within six months prior to transplant suggestive of chronic use or tolerance; however, 30% of those that did not fully follow our ERAS pathway were discharged with non-opioids. Reasons for deviation from those in the ERAS cohort were any use of oxycodone inpatient or script of oxycodone at discharge (n=25, 83.3%) and/or requirement of intravenous pain medications beyond post-operative day one (n=11, 36.7%).

*Conclusions: Multimodal analgesia within the ERAS pathway is beneficial in KTRs to provide adequate pain control with limited to no exposure of opioids during admission or at discharge without adversely affecting outcomes.

Outcomes
Non-ERAS (n=147) ERAS (n=70) p-value
Inpatient Opioid Use (MME/day) 24.7 + 19.7 16.5 + 19.2 0.004
Length of Stay (days)  7.3 + 5.8 7.1 + 6.4 0.8
Opioid Use Post-Discharge No Use 10 (7) 35 (50) <0.005
Level 1: >0 to 150 mg 1 (0.6) 9 (13) <0.005
Level 2: 151-300 mg 10 (7) 5 (7) 0.926
Level 3: 301-500 mg 89 (61) 15 (21) <0.005
Level 4: >500 mg 37 (25) 6 (9) 0.007
  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Muir MA, Szempruch KR, Dupuis RE, Toledo AH, Rodriguez PSerrano. Evaluating Postoperative Opioid Requirements of Kidney Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/evaluating-postoperative-opioid-requirements-of-kidney-transplant-recipients/. Accessed January 16, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients
  • How To Handle a Missed or Delayed Dose Intake? A Pharmacokinetic Study of Cyclosporine and Tacrolimus in Renal Transplant Patients
  • Hyperkalemia in the Early Post Renal Transplant Period
  • Direct Oral Anticoagulation Use in Kidney Transplant Recipients

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.